Joincare Pharmaceutical Group Industry Co.,Ltd. Stock price
Equities
600380
CNE000001816
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.9 CNY | -0.91% | -7.08% | -12.31% |
Feb. 23 | Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug | MT |
Jan. 30 | Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President | MT |
Sales 2023 * | 16.49B 2.28B | Sales 2024 * | 18.17B 2.51B | Capitalization | 20.2B 2.8B |
---|---|---|---|---|---|
Net income 2023 * | 1.39B 192M | Net income 2024 * | 1.63B 226M | EV / Sales 2023 * | 1.23 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.11 x |
P/E ratio 2023 * |
14.8
x | P/E ratio 2024 * |
12.6
x | Employees | 14,116 |
Yield 2023 * |
1.56% | Yield 2024 * |
1.74% | Free-Float | 47.88% |
1 day | -0.91% | ||
1 week | -7.08% | ||
Current month | -9.77% | ||
1 month | -9.02% | ||
3 months | -11.45% | ||
6 months | -11.81% | ||
Current year | -12.31% |
Managers | Title | Age | Since |
---|---|---|---|
Xiong Yu
PSD | President | 63 | 21-08-26 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
Zhi Wei Xing
BRD | Director/Board Member | 38 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Guo Zhu
FOU | Founder | 62 | 92-12-17 |
Guang Xia Liu
BRD | Director/Board Member | 55 | 12-08-27 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.36% | 2 M€ | -16.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 10.9 | -0.91% | 7,899,900 |
24-03-26 | 11 | -1.26% | 13,611,520 |
24-03-25 | 11.14 | -0.71% | 7,485,154 |
24-03-22 | 11.22 | -3.03% | 16,968,590 |
24-03-21 | 11.57 | -1.36% | 7,604,379 |
End-of-day quote Shanghai S.E., March 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.31% | 2.81B | |
+35.39% | 701B | |
+26.24% | 571B | |
+1.13% | 381B | |
+20.57% | 334B | |
+16.88% | 319B | |
+0.80% | 210B | |
+2.17% | 210B | |
-6.34% | 201B | |
-3.37% | 157B |